Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback